Carcinoma
Reports on carcinoma findings from St. Marianna University, Department of General Surgery provide new insights
Published in Cancer Weekly, May 1st, 2007
Research findings, "A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses," are discussed in a new report. According to a study from Kawasaki, Japan, "Ascites tumor cells from patients with peritonitis carcinomatosa were tested for cis-diamminedichloroplatinum (CDDP) sensitivity. The patients were divided into CDDP-sensitive and resistant groups."
"Survival and time to progression (TTP) rates were compared. 18 peritonitis carcinomatosa patients with class V ascites based on cytologic diagnosis were enrolled in this study. Chemosensitivity testing of the ascites tumor cells...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-01)
More Articles from Cancer Weekly
- Cancer
Researcher focuses on pros, cons of antioxidants from fruits and vegetables - Cancer Gene Therapy
Gelatin-Based Nanoparticle Effective in Gene Therapy for Breast Cancer - Cancer Gene Therapy
Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer - Cancer Vaccines
Breast cancer vaccine stimulates potent immune response to cancer cells - Cancer Vaccines
Head and neck cancer vaccine targets proteins to create immune response - Cancer Vaccines
Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
